Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603

Watchlist Manager
Shijiazhuang Yiling Pharmaceutical Co Ltd Logo
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Watchlist
Price: 16.83 CNY -3.99% Market Closed
Market Cap: 28.1B CNY
Have any thoughts about
Shijiazhuang Yiling Pharmaceutical Co Ltd?
Write Note

Shijiazhuang Yiling Pharmaceutical Co Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shijiazhuang Yiling Pharmaceutical Co Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Total Liabilities & Equity
ÂĄ17B
CAGR 3-Years
9%
CAGR 5-Years
14%
CAGR 10-Years
13%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Liabilities & Equity
ÂĄ33B
CAGR 3-Years
17%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Liabilities & Equity
ÂĄ17B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
18%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Liabilities & Equity
ÂĄ48.2B
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
19%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Liabilities & Equity
ÂĄ54.4B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
15%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Liabilities & Equity
ÂĄ1.4B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shijiazhuang Yiling Pharmaceutical Co Ltd
Glance View

Market Cap
28.1B CNY
Industry
Pharmaceuticals

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the pharmaceutical manufacturing. The company is headquartered in Shijiazhuang, Hebei and currently employs 15,155 full-time employees. The company went IPO on 2011-07-28. The firm mainly provides cardiovascular and cerebrovascular drugs and anti-cold drugs. The firm also provides food and beverage products. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
20.09 CNY
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
17B CNY

Based on the financial report for Sep 30, 2024, Shijiazhuang Yiling Pharmaceutical Co Ltd's Total Liabilities & Equity amounts to 17B CNY.

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
13%

Over the last year, the Total Liabilities & Equity growth was -3%. The average annual Total Liabilities & Equity growth rates for Shijiazhuang Yiling Pharmaceutical Co Ltd have been 9% over the past three years , 14% over the past five years , and 13% over the past ten years .

Back to Top